Rearming the body’s immune system to fight cancer

We’re developing more precise and more accessible treatment alternatives for patients with solid cancers

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.

Learn more about us

Some of our partners

Latest news

Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Ovarian Cancer

By Karen Loudon / February 27, 2023
Melbourne, Victoria, Australia 27 February 2023 Peter MacCallum Cancer Centre (“Peter Mac”) and Cartherics Pty Ltd (“Cartherics”) announced today they...
Read More

Cartherics is ‘Turning Teal’ this February in support of ovarian cancer

By Karen Loudon / February 22, 2023
Cartherics is delighted to be hosting a Teal Tea this February to raise awareness and funds for people affected by...
Read More

Cartherics celebrates PhD student’s success

By Karen Loudon / February 6, 2023
Cartherics is delighted to announce that Saleh Almasabi has successfully completed his PhD Candidature. Saleh’s research thesis, ‘The role of...
Read More